GlassScriptPhysician profile
Sandeep S Gupta
NPI 1194990945
$9,023.04
in general payments reported to CMS, 2019-2025
27 companies · $6,423 in 2025
The $6,423 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,637 · 2020: $478 · 2021: $274 · 2022: $43.66 · 2023: $16.15 · 2024: $152 · 2025: $6,423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,517 · Travel and Lodging: $657 · Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,517.38 |
| Travel and Lodging | $656.50 |
| Food and Beverage | $416.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,386.21 | 2025 | |
| Olympus Corporation of The Americas | $785.82 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $337.16 | 2019-2021 | |
| Glaxosmithkline, LLC. | $289.00 | 2019-2020 | |
| Inspire Medical Systems, INC. | $244.74 | 2021-2024 | Inspire |
| Mylan Specialty L.P. | $233.86 | 2019-2021 | |
| Insmed, INC. | $139.44 | 2019-2025 | Brinsupri |
| Genzyme Corporation | $74.54 | 2019-2020 | |
| Philips North America LLC | $60.89 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $57.25 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.90 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $45.93 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $45.89 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.97 | 2020-2021 | |
| Electromed, INC. | $36.44 | 2023-2024 | Smartvest |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $24.08 | 2019 | |
| Itamar Medical INC | $19.62 | 2024 | Watchpatone |
| Mallinckrodt Hospital Products INC. | $19.27 | 2025 | Acthar |
| Advanced Respiratory, INC | $19.00 | 2019 | |
| Genentech USA, INC. | $18.93 | 2020 | |
| Jazz Pharmaceuticals INC. | $17.47 | 2019 | |
| United Therapeutics Corporation | $13.84 | 2021 | |
| Veran Medical Technologies, INC. | $13.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.04 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.71 | 2020 | |
| Supernus Pharmaceuticals, INC. | $12.23 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.